The DLA Piper LLP (US) team advises pharma and medical device clients on complex product liability, mass tort, and class action defense across the US. The practice is led by Christopher Campbell, based in Atlanta, and Loren Brown, located in New York. Campbell focuses on global mass tort litigation involving contraceptives, implantable devices, consumer class actions over alleged labeling issues, and claims relating to drug safety and device use. Brown concentrates on obesity and diabetes medications as well as medical devices, focusing on vision-loss allegations. In Boston, Katie Insogna regularly acts as lead trial counsel across multiple jurisdictions, while Matthew Holian handles alleged carcinogen and economic-loss claims involving medications as well as allegations surrounding injectable contraceptives. Lucas Przymusinski in New York supports Brown on obesity and diabetes matters, including alleged gastrointestinal injuries and early-stage resolutions.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Billing & efficiency
Testimonials
Collated independently by Legal 500 research team.
‘The DLA Team is deeply fluent in the scientific and regulatory issues that drive pharmaceutical and medical device litigation and bring that fluency to bear early by shaping the record, sharpening expert strategy, and positioning cases for dispositive outcomes or trial readiness.'
'It is a real pleasure to work with Christopher Campbell and Mary Gately as they are not only excellent lawyers, but are also always available when needed and provide their work in a way that does not need any "translation" for the business to understand. I can only highly recommend working with them.'
'What differentiates the team in my experience is the seamless integration between trial lawyers, appellate specialists, regulatory/FDA counsel, and a rigorous internal science bench.’
'The team can master and simplify complex science without losing sight of business objectives. Their approach is collaborative and solution-oriented, and they deliver results.’
‘Christopher Campbell and Mary Gately are our leading coordination counsel in complex, cross-border litigation cases. They have excellent strategic judgement, keep the big picture in mind, and are always a few steps ahead.'
'Christopher Campbell is the strategic mastermind for complex topics, and Mary Gately has in-depth knowledge of all the scientific issues and excellent strategic advice on this part.’
Key clients
- 3M Company, The
- B. Braun Medical Inc.
- Bayer Corporation
- Danone
- Johnson & Johnson
- Medtronic, Inc.
- Novo Nordisk A/S
- Pfizer
- Sanofi
- Stryker
Work highlights
Represented as co-national counsel for Sanofi in matters related to Zantac, a heartburn medication allegedly contaminated with NDMA, a possible carcinogen.
Represented Novo Nordisk as national trial counsel and global coordinating counsel related to its diabetes and obesity medications, Ozempic, Wegovy, and Rybelsus, as well as Victoza and Saxenda.
Represented Bayer as global coordinating counsel in the Essure Australia class action.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Loren Brown; Ilana Hope Eisenstein; Christopher Campbell; Angela Agrusa; Keara Gordon; Isabelle Ord
Other key lawyers
Katie Insogna; Lucas Przymusinski; Mary Gately; Matthew Holian;